suicide gene therapy (Tulane/Schering-Plough)
N/A
Report date: 2025/02/01 20:00:06
Base Information
Drug Namesuicide gene therapy (Tulane/Schering-Plough)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTulane University
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesSchering-Plough Research InstituteTulane University
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A